Clinical Research Directory

Inclusion Criteria: 1. Age \>=18 years. 2. Able to understand study procedures and to comply with them for the entire length of the study. 3. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. 4. Diagnosed with any malignancy and/or received any cancer directed therapy within 5 years of enrollment. 5. Be able to speak, read and write in English. 6. Self-identify as Black or African American race. 7. Reside in California. Exclusion Criteria: 1. Contraindication to any study-related procedure or assessment. a. Participants complete the PAR-Q at screening to ensure that they are physically well enough to enroll in the study. If they report any conditions that may be contraindications to physical activity, physician clearance will be required prior to enrollment. 2. Planned major surgery during the study period. 3. Any major injuries that limit physical activity. 4. Active or radiographic evidence of cancer requiring treatment during the study period. Adjuvant therapy is allowed (including hormonal, immuno-, or targeted therapy). Ongoing treatment such as hormone or maintenance therapies including HER2 directed, or immunotherapy are only allowed if patient has no evidence of disease on most recent imaging.